Winstrol 50mg 50 Tablets Nakon Medical USA
$99.00
Product Short Description
Winstrol 50 mg 50 Tablets Nakon Medical USA delivers stanozolol (C21H32N2O), the pyrazole-fused DHT anabolic steroid exhibiting extreme anabolic potency (~320:30 ratio), at premium oral 50 mg strength matching institutional performance specifications. Domestic production serves DEA Schedule III compliant channels exclusively.
Product Overview
Nakon Medical USA’s Winstrol 50 mg presents stanozolol, featuring heterocyclic pyrazole ring substitution preventing aromatization characteristic of 17α-methylated DHT derivatives, in scored tablets for institutional catalogs. The 50-tablet tamper-evident configuration supports CIII-compliant inventory management across encrypted specialist platforms requiring batch traceability essential for DEA-regulated workflows.
U.S. domestic manufacturing eliminates customs exposure while maintaining USP-equivalent specifications (white scored tablets, ~8-hour half-life) distinguishing legitimate Schedule III supply from underground presses prevalent in non-verified markets. This high-dosage format serves advanced resellers managing controlled substance inventories rather than prescription crossover.
Winstrol targets verified CIII ecosystems emphasizing commercial positioning without protocols or claims.
Brand & Manufacturer Information
Nakon Medical USA produces Schedule III anabolics through domestic facilities serving institutional performance distribution requiring controlled substance compliance. Winstrol 50 mg maintains catalog continuity alongside Nakon high-potency orals authenticating legitimate institutional supply versus powder-converted alternatives.
Domestic warehousing supports DEA Form 222 record-keeping confirming stanozolol identity/potency across encrypted platforms.
Active Compound Information
Contains stanozolol (17α-methyl-2’H-5α-androst-2-enopyrazol-17β-ol), C2-C3 pyrazole fused DHT derivative enabling high anabolic:androgenic dissociation with no estrogen conversion and moderate hepatotoxicity profile characteristic of 17α-methylated oral steroids. DEA Schedule III (21 CFR 1308.13) classification reflects performance dosage escalation potential.
50 mg strength represents institutional-grade escalation from discontinued 2 mg Winstrol prescription. WADA S1a prohibited globally.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Winstrol 50 mg 50 Tablets Nakon Medical USA |
| Active Compound | Stanozolol (C21H32N2O) |
| Strength | 50 mg per scored tablet |
| Quantity | 50 tablets per bottle |
| Form | Oral scored tablets |
| Category | DEA Schedule III controlled substance |
| Packaging | Tamper-evident HDPE bottle |
| Label Elements | 50 mg declaration, batch code, CIII warnings |
Quality Control & Testing Standards
50 mg stanozolol requires USP potency assay (90-110% HPLC), dissolution profiling (Q=80% 30 min), and uniformity verification confirming pharmaceutical-grade content. Nakon batch documentation verifies C21H32N2O identity and Schedule III-compliant excipients distinguishing legitimate production.
50-tablet institutional bottling prevents diversion matching DEA protocols; domestic warehousing maintains stability versus underground alternatives.
Intended Use & Market Positioning
Serves CIII-licensed institutional researchers managing high-dosage DEA Schedule III oral anabolic inventories exclusively. 50 mg/50-tab excludes crossover within premium domestic catalogs. No protocols represented.
Legal & Regulatory Disclaimer
Stanozolol constitutes DEA Schedule III under 21 USC §812; non-medical handling violates Controlled Substances Act (5 years/$250,000 penalties). Buyer assumes Form 222 compliance; zero medical claims provided.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.